Novo Nordisk, the pharmaceutical company behind Ozempic, has launched a national campaign promoting its injectable ...
Not only has the Danish economy benefited from the success of Ozempic and Wegovy, two more weight-management medications ...
FAT jabs could be the cancer hope of the future after early studies found they reduce the risk of tumours. The world’s top ...
Novo Nordisk A/S NVO is facing a significant challenge in China, where local pharmaceutical companies are developing generic ...
Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are ...
Several promising drugs in phase 2 testing and beyond seek to offer patients a more convenient alternative to already popular ...
The company reported $175.8 million in sales of Zepbound in the first few weeks of its launch in December. The drug, ...
Eli Lilly and Novo Nordisk are, so far, the kings of the weight-loss gold rush. Thanks to their medicines, Zepbound and ...
Kroger Health, the arm of grocer Kroger that runs pharmacies and clinics across the U.S., said on Friday it had revamped its ...
Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are ...
07.06.24 Five-year data for Roche’s Evrysdi show the majority of treated children with a severe form of spinal muscular atrophy (SMA) achieved or maintained the ability to sit, stand or walk ...